<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28857649</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month><Day>02</Day></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.</ArticleTitle><Pagination><StartPage>2543</StartPage><EndPage>2547</EndPage><MedlinePgn>2543-2547</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2017.1359454</ELocationID><Abstract><AbstractText>It remains uncertain whether HIV-exposed uninfected (HEU) infants have impaired responses to oral vaccines. We performed a cross-sectional study of 6-month-old infants recruited at birth to the ZVITAMBO trial in Zimbabwe between 1997-2001, before introduction of prevention of mother-to-child transmission interventions. We measured poliovirus-specific IgA to type 1-3 polio strains by semi-quantitative capture ELISA in cryopreserved serum samples collected from 85 HEU and 101 HIV-unexposed infants at 6 months of age, one month after their last immunisation with trivalent OPV. Almost all infants were breastfed, with the majority in both groups mixed breastfed (70.6% HEU versus 71.3% HIV-unexposed). Median (IQR) vaccine titers for HEU and HIV-unexposed infants were 1592 (618-4896) vs. 1774 (711-5431) for Sabin 1 (P = 0.46); 1895 (810-4398) vs. 2308 (1081-4283) for Sabin 2 (P = 0.52); and 1798 (774-4192) vs. 2260 (996-5723) for Sabin 3 (P = 0.18). There were no significant differences in vaccine titers between HEU and HIV-unexposed infants, suggesting that vertical HIV exposure does not impact oral poliovirus vaccine immunogenicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Church</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Blizard Institute , Queen Mary University of London , London , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rukobo</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Govha</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmolli</LastName><ForeName>Marya P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>c Department of Medicine, Vaccine Testing Center , University of Vermont , Burlington , VT , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diehl</LastName><ForeName>Sean A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>c Department of Medicine, Vaccine Testing Center , University of Vermont , Burlington , VT , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chasekwa</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntozini</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mutasa</LastName><ForeName>Kuda</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphrey</LastName><ForeName>Jean H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Department of International Health , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Beth D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>c Department of Medicine, Vaccine Testing Center , University of Vermont , Burlington , VT , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prendergast</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>a Zvitambo Institute for Maternal and Child Health Research , Harare , Zimbabwe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Blizard Institute , Queen Mary University of London , London , UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Department of International Health , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018445" MajorTopicYN="N">Infectious Disease Transmission, Vertical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009035" MajorTopicYN="N">Mothers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015030" MajorTopicYN="N">Zimbabwe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">OPV</Keyword><Keyword MajorTopicYN="N">infants</Keyword><Keyword MajorTopicYN="N">oral vaccine</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28857649</ArticleId><ArticleId IdType="pmc">PMC5703368</ArticleId><ArticleId IdType="doi">10.1080/21645515.2017.1359454</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis. 2016;16(6):e92-e107. doi:10.1016/S1473-3099(16)00055-4. PMID:27049574</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)00055-4</ArticleId><ArticleId IdType="pubmed">27049574</ArticleId></ArticleIdList></Reference><Reference><Citation>Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health. 2009;14(3):276-87. doi:10.1111/j.1365-3156.2009.02220.x. PMID:19171011</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2009.02220.x</ArticleId><ArticleId IdType="pubmed">19171011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr. 1985;107(3):352-7. doi:10.1016/S0022-3476(85)80505-9. PMID:4032129</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(85)80505-9</ArticleId><ArticleId IdType="pubmed">4032129</ArticleId></ArticleIdList></Reference><Reference><Citation>Shearer WT, Easley KA, Goldfarb J, Rosenblatt HM, Jenson HB, Kovacs A, McIntosh K. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol. 2000;106(3):559-66. doi:10.1067/mai.2000.109433. PMID:10984378</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mai.2000.109433</ArticleId><ArticleId IdType="pmc">PMC4360071</ArticleId><ArticleId IdType="pubmed">10984378</ArticleId></ArticleIdList></Reference><Reference><Citation>Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014;176(1):11-22. doi:10.1111/cei.12251. PMID:24325737</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12251</ArticleId><ArticleId IdType="pmc">PMC3958150</ArticleId><ArticleId IdType="pubmed">24325737</ArticleId></ArticleIdList></Reference><Reference><Citation>Polio Eradication &amp; Endgame Strategic Plan 2013-2018; Polio Global Eradication Initiative.
Geneva: World Health Organisation; 2013 [accessed 2016 Nov 8]. Available at: http://polioeradication.org/wp-content/uploads/2016/07/PEESP_EN_A4.pdf</Citation></Reference><Reference><Citation>Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13(5):926-39. doi:10.1093/clinids/13.5.926. PMID:1660184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/13.5.926</ArticleId><ArticleId IdType="pubmed">1660184</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, Bruce Aylward R. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis. 2010;201(10):1535-43. doi:10.1086/651952. PMID:20367459</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/651952</ArticleId><ArticleId IdType="pubmed">20367459</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque R, Snider C, Liu Y, Ma JZ, Liu L, Nayak U, Mychaleckyj JC, Korpe P, Mondal D, Kabir M, et&#xa0;al.. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine. 2014;32(4):478-82. doi:10.1016/j.vaccine.2013.11.056. PMID:24300591</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.11.056</ArticleId><ArticleId IdType="pmc">PMC4936916</ArticleId><ArticleId IdType="pubmed">24300591</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado YA, Pe&#xf1;a-Cruz V, de la Luz Sanchez M, Logan L, Bland&#xf3;n S, Cantwell MF, Matsui SM, Millan-Velasco F, Valdespino JL, Sepulveda J. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children. J Infect Dis. 1997;175(3):545-53. doi:10.1093/infdis/175.3.545. PMID:9041324</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/175.3.545</ArticleId><ArticleId IdType="pmc">PMC7110245</ArticleId><ArticleId IdType="pubmed">9041324</ArticleId></ArticleIdList></Reference><Reference><Citation>Posey DL, Linkins RW, Oliveria MJ, Monteiro D, Patriarca PA. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis. 1997;175 Suppl 1:S258-63. doi:10.1093/infdis/175.Supplement_1.S258. PMID:9203726</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/175.Supplement_1.S258</ArticleId><ArticleId IdType="pubmed">9203726</ArticleId></ArticleIdList></Reference><Reference><Citation>Triki H, MV Abdallah, Ben Aissa R, Bouratbine A, Ben Ali Kacem M, Bouraoui S, Koubaa C, Zouari S, Mohsni E, Crainic R, et&#xa0;al.. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine. 1997;15(10):1123-9. doi:10.1016/S0264-410X(97)00001-7. PMID:9269056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(97)00001-7</ArticleId><ArticleId IdType="pubmed">9269056</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, Mychaleckyj JC, Kirkpatrick B, Colgate R, Carmolli M, et&#xa0;al.. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine. 2015;2(11):1759-66. doi:10.1016/j.ebiom.2015.09.036. PMID:26870801</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.09.036</ArticleId><ArticleId IdType="pmc">PMC4740306</ArticleId><ArticleId IdType="pubmed">26870801</ArticleId></ArticleIdList></Reference><Reference><Citation>Troy SB, Musingwini G, Halpern MS, Huang C, Stranix-Chibanda L, Kouiavskaia D, Shetty AK, Chumakov K, Nathoo K, Maldonado YA. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants. J Infect Dis. 2013;208(4):672-8. doi:10.1093/infdis/jit208. PMID:23661792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit208</ArticleId><ArticleId IdType="pmc">PMC3719901</ArticleId><ArticleId IdType="pubmed">23661792</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305(6):576-84. doi:10.1001/jama.2011.100. PMID:21304083</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.100</ArticleId><ArticleId IdType="pubmed">21304083</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhi SA, Izu A, Violari A, Cotton MF, Panchia R, Dobbels E, Sewraj P, van Niekerk N, Jean-Philippe P, Adrian PV. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants. Vaccine. 2013;31(5):777-83. doi:10.1016/j.vaccine.2012.11.076. PMID:23228814</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.11.076</ArticleId><ArticleId IdType="pmc">PMC3646262</ArticleId><ArticleId IdType="pubmed">23228814</ArticleId></ArticleIdList></Reference><Reference><Citation>Reikie BA, Naidoo S, Ruck CE, Slogrove AL, de Beer C, la Grange H, Adams RC, Ho K, Smolen K, Speert DP, et&#xa0;al., Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the First 2&#xa0;years of life. Clin Vaccine Immunol. 2013;20(1):33-8. doi:10.1128/CVI.00557-12. PMID:23114697</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00557-12</ArticleId><ArticleId IdType="pmc">PMC3535768</ArticleId><ArticleId IdType="pubmed">23114697</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani OE, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, Madhi SA. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. Aids. 2014;28(4):531-41. doi:10.1097/QAD.0000000000000127. PMID:24468996</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000000127</ArticleId><ArticleId IdType="pubmed">24468996</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guerin (BCG) vaccine in HIV-uninfected infants. Immunology. 2010;129(3):446-54. doi:10.1111/j.1365-2567.2009.03186.x. PMID:20002789</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2009.03186.x</ArticleId><ArticleId IdType="pmc">PMC2826689</ArticleId><ArticleId IdType="pubmed">20002789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz-Ramos M, Manno D, Kapambwe M, Ndumba I, Musonda KG, Bates M, Chibumbya J, Siame J, Monze M, Filteau S, et&#xa0;al.. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine. 2013;31(16):2042-9. doi:10.1016/j.vaccine.2013.02.044. PMID:23474309</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.02.044</ArticleId><ArticleId IdType="pubmed">23474309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejiokem MC, Gouandjika I, B&#xe9;niguel L, Zanga MC, Tene G, Gody JC, Njamkepo E, Kfutwah A, Penda I, Bilong C, et&#xa0;al.. HIV-Infected children living in Central Africa have low persistence of antibodies to vaccines used in the expanded program on immunization. Plos One. 2007;2(12):e1260. doi:10.1371/journal.pone.0001260. PMID:18060056</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001260</ArticleId><ArticleId IdType="pmc">PMC2093997</ArticleId><ArticleId IdType="pubmed">18060056</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, Mutasa K, Ruff A, Ward B. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J. 2011;30(1):45-51. doi:10.1097/INF.0b013e3181ecbf7e. PMID:21173675</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181ecbf7e</ArticleId><ArticleId IdType="pubmed">21173675</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaensbauer JT, Rakhola JT, Onyango-Makumbi C, Mubiru M, Westcott JE, Krebs NF, Asturias EJ, Fowler MG, McFarland E, Janoff EN. Impaired Haemophilus influenzae Type b Transplacental antibody transmission and declining antibody avidity through the first year of life represent Potential Vulnerabilities for HIV-Exposed but - uninfected infants. Clin Vaccine Immunol. 2014;21(12):1661-7. doi:10.1128/CVI.00356-14. PMID:25298109</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00356-14</ArticleId><ArticleId IdType="pmc">PMC4248779</ArticleId><ArticleId IdType="pubmed">25298109</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, Moulton LH, Salama P, Ward BJ. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26(6):519-26. doi:10.1097/01.inf.0000264527.69954.4c. PMID:17529870</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000264527.69954.4c</ArticleId><ArticleId IdType="pubmed">17529870</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson RS. Principles of Nutritional Assessment. Second ed Oxford, UK: Oxford University Press; 1990. p. 712.</Citation></Reference><Reference><Citation>Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, Moulton LH, Ward BJ, Humphrey JH. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19(7):699-708. doi:10.1097/01.aids.0000166093.16446.c9. PMID:15821396</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.aids.0000166093.16446.c9</ArticleId><ArticleId IdType="pubmed">15821396</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Immunization coverage: reported coverage by country, year and vaccine. 15thJuly2016
24thOctober2016]; Immunization coverage per country, year and disease dating back to 1980]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragebcg.html.</Citation></Reference><Reference><Citation>Ivanov AP, Dragunsky EM. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Rev Vaccines. 2005;4(2):167-72. doi:10.1586/14760584.4.2.167. PMID:15889990</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.4.2.167</ArticleId><ArticleId IdType="pubmed">15889990</ArticleId></ArticleIdList></Reference><Reference><Citation>Simhon A, Lifshitz A, Abed Y, Lasch EE, Schoub B, Morag A. How to Predict the Immune Status of Poliovirus Vaccinees - a Comparison of Virus Neutralization at a Very Low Serum Dilution Versus Elisa in a Cohort of Infants. Int J Epidemiol. 1990;19(1):164-8. doi:10.1093/ije/19.1.164. PMID:2161806</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/19.1.164</ArticleId><ArticleId IdType="pubmed">2161806</ArticleId></ArticleIdList></Reference><Reference><Citation>Gary BE, Freeman C, Pe&#xf1;aranda S, Maher K, Anderson L, Pallansch MA. Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine. J Infect Dis. 1997;175:S264-7. doi:10.1093/infdis/175.Supplement_1.S264. PMID:9203727</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/175.Supplement_1.S264</ArticleId><ArticleId IdType="pubmed">9203727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashido M, Horie H, Abe S, Doi Y, Hashizume S, Agboatwalla M, Isomura S, Nishio O, Hagiwara A, Inouye S. Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies. Microbiol Immunol. 1999;43(1):73-7. doi:10.1111/j.1348-0421.1999.tb02375.x. PMID:10100750</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.1999.tb02375.x</ArticleId><ArticleId IdType="pubmed">10100750</ArticleId></ArticleIdList></Reference><Reference><Citation>Herremans T, Kimman TG, Conyn-Van Spaendonck MA, Buisman A, de Melker H, Abbink F, Bijkerk P, Koopmans MP. Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population. Clin Infect Dis. 2002;34(8):1067-75. doi:10.1086/339489. PMID:11914995</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/339489</ArticleId><ArticleId IdType="pubmed">11914995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, Ackerman ME, van der Avoort H, Oberste MS, Pallansch MA, et&#xa0;al.. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. J Infect Dis. 2014;209(10):1628-34. doi:10.1093/infdis/jit671. PMID:24459191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit671</ArticleId><ArticleId IdType="pubmed">24459191</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DJ, Gahnberg L, Taubman MA, Ebersole JL. Salivary antibody responses to oral and parenteral vaccines in children. J Clin Immunol. 1986;6(1):43-9. doi:10.1007/BF00915363. PMID:3958136</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00915363</ArticleId><ArticleId IdType="pubmed">3958136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599. doi:10.1371/journal.ppat.1002599. PMID:22532797</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002599</ArticleId><ArticleId IdType="pmc">PMC3330118</ArticleId><ArticleId IdType="pubmed">22532797</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldon WC, Oberste MS, Pallansch MA. Standardized methods for detection of poliovirus antibodies. Methods Mol Biol. 2016;1387:145-76. doi:10.1007/978-1-4939-3292-4_8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_8</ArticleId><ArticleId IdType="pubmed">26983734</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>